Wei Gao
Education
Ph.D., biostatistics, Boston University; M.S., biostatistics, The George Washington University; B.S., mathematics, Fudan University
Summary of Experience
Dr. Gao specializes in developing innovative statistical methodologies and applying them to the study of clinical and economic outcomes in a broad range of disease areas. He has led and implemented analyses across entire product lifecycles, from early-phase clinical trials to post-market real-world evidence generation. Dr. Gao has particular expertise in retrospective data and clinical trial data analysis, health economics modeling, indirect treatment comparisons, predictive analytics, meta-analyses, individualized medicine, and statistical genetics. His research has supported the launches of several pharmaceutical products and has been widely published in leading peer-reviewed journals, including The New England Journal of Medicine, JAMA, Nature Genetics, Nature Communications, and the American Journal of Respiratory and Critical Care Medicine. He has presented his work at multiple statistical and health care conferences.
-
Trends in Prevalence and Incidence of Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Among Adults and Children in a US Employer-Sponsored Insured Population
JAMA Dermatology, 2023
2023Mostaghimi A, Gao W, Ray M, Bartolome L, Wang T, Carley C, Done N, Swallow E
HEOR, Epidemiology & Market Access -
Clinical Outcomes, Resource Utilization, and Treatment over the Disease Course of Symptomatic Obstructive Hypertrophic Cardiomyopathy in the United States
American Journal of Cardiology, 2023
2023Desai NR, Sutton MB, Xie J, Fine JT, Gao W, Owens AT, Naidu SS
HEOR, Epidemiology & Market Access -
Patient Characteristics Associated with All-Cause Healthcare Costs of Alopecia Areata in the United States
Journal of Medical Economics, 2023
2023Gao W, Mostaghimi A, Gandhi K, Done N, Ray M, Signorovitch J, Swallow E, Carley C, Wang T, Sikirica V
HEOR, Epidemiology & Market Access -
Frequency and Clinicoeconomic Impact of Delays to Definitive Diagnosis of Obstructive Hypertrophic Cardiomyopathy in the United States
Journal of Medical Economics, 2023
2023Naidu SS, Sutton MB, Gao W, Fine JT, Xie J, Desai NR, Owens AT
HEOR, Epidemiology & Market Access -
Long-term burden of respiratory complications associated with extreme prematurity: An analysis of US Medicaid claims
Pediatrics & Neonatology, 2022
2022Mowitz ME, Gao W, Sipsma H, Zuckerman P, Wong H, Ayyagari R, Sarda SP, Siffel C
HEOR, Epidemiology & Market Access -
Interdisciplinary Model-Informed Drug Development for Extending Duration of Elagolix Treatment in Patients with Uterine Fibroids
British Journal of Clinical Pharmacology, 2022
2022Beck D, Winzenborg I, Gao W, Mostafa NM, Chiuve SE, Owens C, Shebley M
HEOR, Epidemiology & Market Access -
All-cause health care resource utilization and costs among adults with alopecia areata: A retrospective claims database study in the United States
Journal of Managed Care & Specialty Pharmacy, 2022
2022Mostaghimi A, Gandhi K, Done N, Ray M, Gao W, Carley C, Wang T, Swallow E, Sikirica V
HEOR, Epidemiology & Market Access -
Treatment Changes, Healthcare Resource Utilization, and Costs Among Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Claims Database Study
Cardiology and Therapy, 2022
2022Owens AT, Sutton MB, Gao W, Fine JT, Xie J, Naidu SS, Desai NR
HEOR, Epidemiology & Market Access -
Indirect Treatment Comparison of Larotrectinib versus Entrectinib in Treating Patients with TRK Gene Fusion Cancers
Cancers (Basel), 2022
2022Garcia-Foncillas J, Bokemeyer C, Italiano A, Keating K, Paracha N, Fellous M, Marian M, Fillbrunn M, Gao W, Ayyagari R, Lassen U
HEOR, Epidemiology & Market Access -
Burden of Comorbidities and Healthcare Resource Utilization among Medicaid-Enrolled Extremely Premature Infants
Journal of Health Economics and Outcomes Research, 2022
2022Mowitz ME, Gao W, Sipsma H, Zuckerman P, Wong H, Ayyagari R, Sarda SP
HEOR, Epidemiology & Market Access -
Integrating real-world data and modeling to project changes in femoral neck bone mineral density and fracture risk in premenopausal women
Clinical and Translational Science, 2021
2021Beck D, Winzenborg I, Gao W, Mostafa NM, Noertersheuser P, Chiuve SE, Owens C, Shebley M
HEOR, Epidemiology & Market Access -
Impact of Medication Adherence on Healthcare Resource Utilization, Work Loss, and Associated Costs in a Privately Insured Employed Population Treated With Adalimumab in the United States
Journal of Occupational and Environmental Medicine, 2021
2021Mittal M, Yang M, Shah M, Gao W, Carley C, Sherman BW
HEOR, Epidemiology & Market Access -
Clinical and economic burden of obstructive hypertrophic cardiomyopathy in the United States
Journal of Medical Economics, 2021
2021Jain SS, Li SS, Xie J, Sutton MB, Fine JT, Edelberg JM, Gao W, Spertus JA, Cohen DJ
HEOR, Epidemiology & Market Access -
Real-world Clinical Outcomes of Pazopanib Immediately After Discontinuation of Immunotherapy for Advanced Renal Cell Carcinoma
Clinical Genitourinary Cancer, 2020
2020Cao X, Tang D, Ratto B, Poole A, Ravichandran S, Jin L, Gao W, Swallow E, Vogelzang NJ
HEOR, Epidemiology & Market Access -
An Economic Evaluation of Pembrolizumab Versus Other Adjuvant Treatment Strategies for Resected High-Risk Stage III Melanoma in the USA
Clinical Drug Investigation, 2020
2020Bensimon AG, Zhou ZY, Jenkins M, Song Y, Gao W, Signorovitch J, Krepler C, Scherrer E, Wang J, Aguiar-Ibáñez R
HEOR, Epidemiology & Market Access -
Estimating the Effect of Elagolix Treatment for Endometriosis on Postmenopausal Bone Outcomes: A Model Bridging Phase III Trials to an Older Real-World Population
JBMR Plus, 2020
2020Kilpatrick RD, Chiuve SE, Leslie WD, Wegrzyn LR, Gao W, Yang H, Soliman AM, Snabes MC, Koenigsberg S, Zhong J, Xiang C, Watts NB
HEOR, Epidemiology & Market Access -
Prevalence of chronic respiratory morbidity, length of stay, inpatient readmissions, and costs among extremely preterm infants with bronchopulmonary dysplasia
Expert Review of Pharmacoeconomics & Outcomes Research, 2020
2020Mowitz ME, Mangili A, Han L, Ayyagari R, Gao W, Wang J, Zhao J, Sarda SP
HEOR, Epidemiology & Market Access -
Cost-effectiveness of olaparib as a maintenance treatment for women with newly diagnosed advanced ovarian cancer and BRCA1/2 mutations in the United States
Gynecologic Oncology, 2020
2020Muston D, Hettle R, Monberg M, McLaurin KK, Gao W, Swallow E, Zhang S, Kalemaj I, Signorovitch J, Moore K
HEOR, Epidemiology & Market Access -
A Critical Appraisal and Recommendations for Cost-Effectiveness Studies of Poly(ADP-Ribose) Polymerase Inhibitors in Advanced Ovarian Cancer
Pharmacoeconomics, 2020
2020Gao W, Muston D, Monberg M, McLaurin K, Hettle R, Szamreta E, Swallow E, Zhang S, Kalemaj I, Signorovitch J, McQueen RB
HEOR, Epidemiology & Market Access -
Real-world healthcare resource utilization related to migraine treatment failure: a panel-based chart review in France, Germany, Italy, and Spain
Journal of Medical Economics, 2019
2019Vo P, Gao W, Zichlin ML, Fuqua E, Fadli E, Vazquez MA, Tarancón T, Mahieu N, Maier-Peuschel M, Rossi S, Naclerio M, Ritrovato D, Swallow E
HEOR, Epidemiology & Market Access -
Migraine-related healthcare resource use in the emergency department setting: a panel-based chart review in France, Germany, Italy, and Spain
Journal of Medical Economics, 2019
2019Vo P, Gao W, Zichlin ML, Fuqua E, Fadli E, Vazquez MA, Tarancón T, Mahieu N, Maier-Peuschel M, Rossi S, Naclerio M, Ritrovato D, Swallow E
HEOR, Epidemiology & Market Access -
Matching-Adjusted Indirect Comparison of Blinatumomab vs. Inotuzumab Ozogamicin for Adults with Relapsed/Refractory Acute Lymphoblastic Leukemia
Advances in Therapy, 2019
2019Song J, Ma Q, Gao W, Cong Z, Xie J, Zimmerman Z, Belton L, Franklin J, Palmer S
HEOR, Epidemiology & Market Access -
Health Care Burden of Bronchopulmonary Dysplasia Among Extremely Preterm Infants
Frontiers in Pediatrics, 2019
2019Mowitz ME, Ayyagari R, Gao W, Zhao J, Mangili A, Sarda SP
HEOR, Epidemiology & Market Access -
Cost-effectiveness of pembrolizumab for the adjuvant treatment of resected high-risk stage III melanoma in the United States
Journal of Medical Economics, 2019
2019Bensimon AG, Zhou ZY, Jenkins M, Song Y, Gao W, Signorovitch J, Krepler C, Liu FX, Wang J, Aguiar-Ibáñez R
HEOR, Epidemiology & Market Access -
Matching-adjusted indirect comparisons of annualized bleeding rate and utilization of BAY 94-9027 versus three recombinant factor VIII agents for prophylaxis in patients with severe hemophilia A
Journal of Blood Medicine, 2019
2019Batt K, Gao W, Ayyagari R, Deschaseaux C, Vashi PB, Yao Z, Wang Y, Kessabi S, Klamroth R
HEOR, Epidemiology & Market Access -
Real-world persistence with fingolimod for the treatment of multiple sclerosis: A systematic review and meta-analysis
Journal of the Neurological Sciences. May 15 2018;388:168-174
2018Kantor D, Johnson K, Vieira MC, Signorovitch J, Li N, Gao W, Koo V, Duchesneau E, Herrera V
HEOR, Epidemiology & Market Access
-
June 27, 2023
-
April 10, 2023
-
March 29, 2022